Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Hold
1,647
0.16% 78
2026
Q1
$358K Hold
1,647
0.15% 79
2025
Q4
$376K Sell
1,647
-223
-12% -$50.8K 0.16% 79
2025
Q3
$433K Buy
+1,870
New +$381K 0.2% 74
2025
Q2
Sell
-1,663
Closed -$348K 26
2025
Q1
$348K Buy
1,663
+16
+1% +$3.11K 0.2% 74
2024
Q4
$293K Hold
1,647
0.18% 78
2024
Q3
$325K Hold
1,647
0.2% 71
2024
Q2
$282K Hold
1,647
0.19% 73
2024
Q1
$300K Sell
1,647
-100
-6% -$17.2K 0.22% 63
2023
Q4
$271K Buy
+1,747
New +$255K 0.21% 62

Other funds holding ABBV

Vawter Financial's ABBV Position: Q2 2026 in Review

Vawter Financial held its AbbVie (ABBV) position steady in Q2 2026 at 1,647 shares worth $414K. The position accounts for 0.16% of the portfolio, ranked #78.

Vawter Financial first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $433K in Q3 2025. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vawter Financial held 1,647 shares of AbbVie worth $414K as of Q2 2026.
  • Vawter Financial left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.16% of Vawter Financial's portfolio in Q2 2026, its #78 holding.
  • Vawter Financial first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Vawter Financial's AbbVie position peaked at $433K in Q3 2025.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vawter Financial's 13F filing for Q2 2026, filed 24 Jul 2026.